Roivant Sciences Ltd [ROIV] is 11.26% higher this YTD. Is it still time to buy?

Roivant Sciences Ltd [NASDAQ: ROIV] traded at a low on 11/06/23, posting a -4.20 loss after which it closed the day’ session at $8.89. The company report on October 30, 2023 at 5:30 PM that Roivant to Report Financial Results for the Second Quarter Ended September 30, 2023, and Provide Business Update on Monday, November 13, 2023.

To access the conference call by phone, please register online using this registration link. The presentation and webcast details will also be available under “Events & Presentations” in the Investors section of the Roivant website at The archived webcast will be available on Roivant’s website after the conference call.

Elon Musk just Triggered a BOOM in These Stocks

Something strange is happening in the stock market…. This select group of stocks are going absolutely bananas. And it's all because of Elon Musk. Get your copy of "Top 5 Tech Stocks to Buy in 2024"

Click Here to Download the FREE Report.


The results of the trading session contributed to over 6884583 shares changing hands. Over the past one week, the price volatility of Roivant Sciences Ltd stands at 5.38% while the volatility over the past one month is 5.37%.

The market cap for ROIV stock reached $7.04 billion, with 760.14 million shares outstanding and 534.17 million shares in the current float. Compared to the average trading volume of 6.21M shares, ROIV reached a trading volume of 6884583 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Roivant Sciences Ltd [ROIV]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ROIV shares is $16.44 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ROIV stock is a recommendation set at 1.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Guggenheim have made an estimate for Roivant Sciences Ltd shares, keeping their opinion on the stock as Buy, with their previous recommendation back on October 17, 2023.

The Average True Range (ATR) for Roivant Sciences Ltd is set at 0.53, with the Price to Sales ratio for ROIV stock in the period of the last 12 months amounting to 89.53. The Price to Book ratio for the last quarter was 7.49, with the Price to Cash per share for the same quarter was set at 1.82.

How has ROIV stock performed recently?

Roivant Sciences Ltd [ROIV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.21. With this latest performance, ROIV shares dropped by -17.69% in over the last four-week period, additionally sinking by -0.78% over the last 6 months – not to mention a rise of 63.42% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ROIV stock in for the last two-week period is set at 40.61, with the RSI for the last a single of trading hit 41.60, and the three-weeks RSI is set at 41.31 for Roivant Sciences Ltd [ROIV]. The present Moving Average for the last 50 days of trading for this stock 10.48, while it was recorded at 8.99 for the last single week of trading, and 9.55 for the last 200 days.

Roivant Sciences Ltd [ROIV]: Deeper insight into the fundamentals

Reflecting on the efficiency of the workforce at the company, Roivant Sciences Ltd [ROIV] managed to generate an average of -$193,201 per employee.Roivant Sciences Ltd’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.35 and a Current Ratio set at 6.37.

Insider trade positions for Roivant Sciences Ltd [ROIV]

The top three institutional holders of ROIV stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2579%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $201.66 billion in ROIV stocks shares; and BERKSHIRE HATHAWAY INC, currently with $177.59 billion in ROIV stock with ownership which is approximately 5.7994%.